Mueller BU - Search Results

1

CBFB-SMMHC is correlated with increased calreticulin expression and suppresses the granulocytic differentiation factor CEBPA in AML with inv(16).

Helbling D, Mueller BU, Timchenko NA, Schardt J, Eyer M, Betts DR, Jotterand M, Meyer-Monard S, Fey MF, Pabst T. Helbling D, et al. Among authors: mueller bu. Blood. 2005 Aug 15;106(4):1369-75. doi: 10.1182/blood-2004-11-4392. Epub 2005 Apr 26. Blood. 2005. PMID: 15855281 Free article.

2

The leukemic fusion gene AML1-MDS1-EVI1 suppresses CEBPA in acute myeloid leukemia by activation of Calreticulin.

Helbling D, Mueller BU, Timchenko NA, Hagemeijer A, Jotterand M, Meyer-Monard S, Lister A, Rowley JD, Huegli B, Fey MF, Pabst T. Helbling D, et al. Among authors: mueller bu. Proc Natl Acad Sci U S A. 2004 Sep 7;101(36):13312-7. doi: 10.1073/pnas.0404731101. Epub 2004 Aug 23. Proc Natl Acad Sci U S A. 2004. PMID: 15326310 Free PMC article.

3

C/EBPalpha and the pathophysiology of acute myeloid leukemia.

Mueller BU, Pabst T. Mueller BU, et al. Curr Opin Hematol. 2006 Jan;13(1):7-14. doi: 10.1097/01.moh.0000190110.08156.96. Curr Opin Hematol. 2006. PMID: 16319681 Review.

4

ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression.

Mueller BU, Pabst T, Fos J, Petkovic V, Fey MF, Asou N, Buergi U, Tenen DG. Mueller BU, et al. Blood. 2006 Apr 15;107(8):3330-8. doi: 10.1182/blood-2005-07-3068. Epub 2005 Dec 13. Blood. 2006. PMID: 16352814 Free PMC article.

5

Unfolded protein response suppresses CEBPA by induction of calreticulin in acute myeloid leukaemia.

Schardt JA, Eyholzer M, Timchenko NA, Mueller BU, Pabst T. Schardt JA, et al. Among authors: mueller bu. J Cell Mol Med. 2010 Jun;14(6B):1509-19. doi: 10.1111/j.1582-4934.2009.00870.x. Epub 2009 Jul 31. J Cell Mol Med. 2010. PMID: 19659458 Free PMC article.

6

Complexity of CEBPA dysregulation in human acute myeloid leukemia.

Pabst T, Mueller BU. Pabst T, et al. Among authors: mueller bu. Clin Cancer Res. 2009 Sep 1;15(17):5303-7. doi: 10.1158/1078-0432.CCR-08-2941. Epub 2009 Aug 25. Clin Cancer Res. 2009. PMID: 19706798 Review.

7

Heterozygous deletion of the PU.1 locus in human AML.

Bonadies N, Pabst T, Mueller BU. Bonadies N, et al. Among authors: mueller bu. Blood. 2010 Jan 14;115(2):331-4. doi: 10.1182/blood-2009-03-212225. Epub 2009 Nov 4. Blood. 2010. PMID: 19890096 Free article.

8

Lineage-specific transcription factor aberrations in AML.

Mueller BU, Pabst T. Mueller BU, et al. Cancer Treat Res. 2010;145:109-25. doi: 10.1007/978-0-387-69259-3_7. Cancer Treat Res. 2010. PMID: 20306248 Review.

9

Deficient CEBPA DNA binding function in normal karyotype AML patients is associated with favorable prognosis.

Fos J, Pabst T, Petkovic V, Ratschiller D, Mueller BU. Fos J, et al. Among authors: mueller bu. Blood. 2011 May 5;117(18):4881-4. doi: 10.1182/blood-2010-11-320747. Epub 2011 Mar 9. Blood. 2011. PMID: 21389317 Free article.

10

Protein disulfide isomerase blocks CEBPA translation and is up-regulated during the unfolded protein response in AML.

Haefliger S, Klebig C, Schaubitzer K, Schardt J, Timchenko N, Mueller BU, Pabst T. Haefliger S, et al. Among authors: mueller bu. Blood. 2011 Jun 2;117(22):5931-40. doi: 10.1182/blood-2010-08-304485. Epub 2011 Apr 6. Blood. 2011. PMID: 21471526 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

171 results

Search Page

Filters